• Je něco špatně v tomto záznamu ?

Synthesis of cytotoxic 2,2-difluoroderivatives of dihydrobetulinic acid and allobetulin and study of their impact on cancer cells

L. Borkova, L. Jasikova, J. Rehulka, K. Frisonsova, M. Urban, I. Frydrych, I. Popa, M. Hajduch, NJ. Dickinson, M. Vlk, P. Dzubak, J. Sarek,

. 2015 ; 96 (-) : 482-90. [pub] 20150401

Jazyk angličtina Země Francie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16010233

In this article, we describe the preparation and cytotoxic properties of a small focused library of lupane and 18α-oleanane triterpenoids that contain a combination of two structural motifs known to enhance the biological activities. First, we introduced two fluorine atoms to position 2 of the skeleton. Second, we synthesized a set of hemiester prodrugs, which were intended to increase the solubility and activity. Starting from betulin, we obtained two hydroxyketones (derivatives of dihydrobetulinic acid and allobetulin) and their fluorination using DAST provided 2,2-difluoro-3-oxo-compounds as the main products. Then the 3-oxo group in each derivative was reduced by NaBH4 to obtain 3β-hydroxy compounds suitable for modifying by various hemiesters. We prepared 21 compounds, 11 of them new, their cytotoxicity was tested on T lymphoblastic leukemia CCRF-CEM cells first and the most active derivatives were selected for screening on another six tumor and two non-tumor cell lines. All of them showed selectivity against cancer lines with therapeutic index between 2 and 8. All hemiesters had activity in the same range as the free hydroxyl derivatives and they would be suitable prodrugs for future in vivo experiments. Interestingly, all hemiesters of 2,2-difluorodihydrobetulonic acid had higher activity against p53 knock-out p53-/- cancer cell line than against the non-mutated analog. In active derivatives, the cell cycle was analyzed by flow cytometry and several compounds slowed down cell cycle progression through G0/G1 or S-phase.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010233
003      
CZ-PrNML
005      
20200728084034.0
007      
ta
008      
160408s2015 fr f 000 0|engg|
009      
AR
024    7_
$a 10.1016/j.ejmech.2015.03.068 $2 doi
024    7_
$a 10.1016/j.ejmech.2015.03.068 $2 doi
035    __
$a (PubMed)25942059
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Borkova, Lucie $u Department of Organic Chemistry, Faculty of Science, Palacky University Olomouc, 17. listopadu 1192/12, 771 46 Olomouc, Czech Republic.
245    10
$a Synthesis of cytotoxic 2,2-difluoroderivatives of dihydrobetulinic acid and allobetulin and study of their impact on cancer cells / $c L. Borkova, L. Jasikova, J. Rehulka, K. Frisonsova, M. Urban, I. Frydrych, I. Popa, M. Hajduch, NJ. Dickinson, M. Vlk, P. Dzubak, J. Sarek,
520    9_
$a In this article, we describe the preparation and cytotoxic properties of a small focused library of lupane and 18α-oleanane triterpenoids that contain a combination of two structural motifs known to enhance the biological activities. First, we introduced two fluorine atoms to position 2 of the skeleton. Second, we synthesized a set of hemiester prodrugs, which were intended to increase the solubility and activity. Starting from betulin, we obtained two hydroxyketones (derivatives of dihydrobetulinic acid and allobetulin) and their fluorination using DAST provided 2,2-difluoro-3-oxo-compounds as the main products. Then the 3-oxo group in each derivative was reduced by NaBH4 to obtain 3β-hydroxy compounds suitable for modifying by various hemiesters. We prepared 21 compounds, 11 of them new, their cytotoxicity was tested on T lymphoblastic leukemia CCRF-CEM cells first and the most active derivatives were selected for screening on another six tumor and two non-tumor cell lines. All of them showed selectivity against cancer lines with therapeutic index between 2 and 8. All hemiesters had activity in the same range as the free hydroxyl derivatives and they would be suitable prodrugs for future in vivo experiments. Interestingly, all hemiesters of 2,2-difluorodihydrobetulonic acid had higher activity against p53 knock-out p53-/- cancer cell line than against the non-mutated analog. In active derivatives, the cell cycle was analyzed by flow cytometry and several compounds slowed down cell cycle progression through G0/G1 or S-phase.
650    _2
$a fytogenní protinádorové látky $x chemická syntéza $x chemie $x farmakologie $7 D000972
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a buněčný cyklus $x účinky léků $7 D002453
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a screeningové testy protinádorových léčiv $7 D004354
650    _2
$a fibroblasty $x účinky léků $7 D005347
650    _2
$a lidé $7 D006801
650    _2
$a fluorované uhlovodíky $x chemická syntéza $x chemie $x farmakologie $7 D006845
650    _2
$a molekulární konformace $7 D008968
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a triterpeny $x chemie $7 D014315
650    _2
$a nádorové buňky kultivované $7 D014407
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Jasikova, Lucie $u Department of Organic and Nuclear Chemistry, Faculty of Science, Charles University in Prague, Hlavova 8, 128 43 Prague 2, Czech Republic.
700    1_
$a Rehulka, Jiri $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00 Olomouc, Czech Republic.
700    1_
$a Frisonsova, Katerina $u Department of Organic and Nuclear Chemistry, Faculty of Science, Charles University in Prague, Hlavova 8, 128 43 Prague 2, Czech Republic.
700    1_
$a Urban, Milan $u Department of Organic Chemistry, Faculty of Science, Palacky University Olomouc, 17. listopadu 1192/12, 771 46 Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00 Olomouc, Czech Republic. $7 xx0117688
700    1_
$a Frydrych, Ivo $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00 Olomouc, Czech Republic.
700    1_
$a Popa, Igor $u Department of Organic Chemistry, Faculty of Science, Palacky University Olomouc, 17. listopadu 1192/12, 771 46 Olomouc, Czech Republic.
700    1_
$a Hajduch, Marian $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00 Olomouc, Czech Republic.
700    1_
$a Dickinson, Niall J $u Department of Organic Chemistry, Faculty of Science, Palacky University Olomouc, 17. listopadu 1192/12, 771 46 Olomouc, Czech Republic.
700    1_
$a Vlk, Martin $u Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Brehova 7, 115 19 Prague 1, Czech Republic.
700    1_
$a Dzubak, Petr $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00 Olomouc, Czech Republic. Electronic address: dzubakp@gmail.com.
700    1_
$a Sarek, Jan $u Department of Organic Chemistry, Faculty of Science, Palacky University Olomouc, 17. listopadu 1192/12, 771 46 Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, 779 00 Olomouc, Czech Republic. Electronic address: jan.sarek@gmail.com.
773    0_
$w MED00001628 $t European journal of medicinal chemistry $x 1768-3254 $g Roč. 96, č. - (2015), s. 482-90
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25942059 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20200728084031 $b ABA008
999    __
$a ok $b bmc $g 1113662 $s 934601
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 96 $c - $d 482-90 $e 20150401 $i 1768-3254 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
LZP    __
$a Pubmed-20160408

Najít záznam

Citační ukazatele

Možnosti archivace